AstraZeneca
AZN
AZN
401 hedge funds and large institutions have $5.76B invested in AstraZeneca in 2014 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 126 increasing their positions, 145 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less capital invested
Capital invested by funds: $7.43B → $5.76B (-$1.67B)
23% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 52
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
401
Holding in Top 10
8
Calls
$1.12B
Puts
$702M
Top Buyers
| 1 | +$88.4M | |
| 2 | +$49.4M | |
| 3 | +$43.4M | |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$32.6M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$31.7M |
Top Sellers
| 1 | -$249M | |
| 2 | -$239M | |
| 3 | -$127M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$123M |
| 5 |
OCAM
Owl Creek Asset Management
New York
|
-$111M |